Who makes Drug: BG-T187?

Drug: BG-T187 is developed by BeiGene.

Last reviewed 2026-04-19 · How we verify

Drug: BG-T187

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

BeiGene · Phase 1 active Small molecule

At a glance

Generic name	Drug: BG-T187
Sponsor	BeiGene
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Drug: BG-T187 CI brief — competitive landscape report
Drug: BG-T187 updates RSS · CI watch RSS
BeiGene portfolio CI